Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Vascular & Endovascular: A new way to battle blood clots | COVID-19 & stroke | TAVR vs MitraClip
Wednesday, January 13, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Vascular & Endovascular

New technique for battling blood clots uses nanodroplets, ultrasound imaging

The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New technique for battling blood clots uses nanodroplets, ultrasound imaging

Share on Twitter Share on Facebook Share on Linkedin
The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.
READ MORE >

Neurologists explain why COVID-19 increases a person’s risk of stroke

The new research, published in Stroke, investigated what happens when COVID-19 interacts with the brain's endothelial cells. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Neurologists explain why COVID-19 increases a person’s risk of stroke

Share on Twitter Share on Facebook Share on Linkedin
The new research, published in Stroke, investigated what happens when COVID-19 interacts with the brain's endothelial cells. 
READ MORE >

Motion sensors confirm that staying active lowers your risk of CVD—and the more you move, the lower the risk

Researchers turned to accelerometers, lightweight motion sensors that can be attached to a user’s wrist, to investigate this topic. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Motion sensors confirm that staying active lowers your risk of CVD—and the more you move, the lower the risk

Share on Twitter Share on Facebook Share on Linkedin
Researchers turned to accelerometers, lightweight motion sensors that can be attached to a user’s wrist, to investigate this topic. 
READ MORE >

Smoking marijuana and tobacco linked to elevated levels of toxic chemicals

Smoking marijuana could be more harmful than many users realize, according to the new research. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Smoking marijuana and tobacco linked to elevated levels of toxic chemicals

Share on Twitter Share on Facebook Share on Linkedin
Smoking marijuana could be more harmful than many users realize, according to the new research. 
READ MORE >

American College of Cardiology shares new guidelines for treating patients with anticoagulant and antiplatelet therapy

The ACC is celebrating the holiday season with a new gift for cardiologists.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology shares new guidelines for treating patients with anticoagulant and antiplatelet therapy

Share on Twitter Share on Facebook Share on Linkedin
women doctors
The ACC is celebrating the holiday season with a new gift for cardiologists.
READ MORE >

In-hospital stroke rates higher after TAVR than MitraClip procedures

Post-discharge stroke rates, however, were similar between the two procedures.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

In-hospital stroke rates higher after TAVR than MitraClip procedures

Share on Twitter Share on Facebook Share on Linkedin
Post-discharge stroke rates, however, were similar between the two procedures.
READ MORE >

Colchicine use proven beneficial for patients with coronary artery disease, according to new meta-analysis

Researchers explored data from more than 11,000 patients.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

Colchicine use proven beneficial for patients with coronary artery disease, according to new meta-analysis

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Researchers explored data from more than 11,000 patients.
READ MORE >

Non‐vitamin K antagonist oral anticoagulants vs. warfarin for AFib patients: What the latest research tells us

Tracking data from more than 10,000 patients, researchers shared their findings in Diabetes, Obesity and Metabolism.

READ MORE >
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Share on Twitter Share on Facebook Share on Linkedin

Non‐vitamin K antagonist oral anticoagulants vs. warfarin for AFib patients: What the latest research tells us

Share on Twitter Share on Facebook Share on Linkedin
durbin-ama-opioid. The American College of Cardiology (ACC) and American Heart Association (AHA) have published new guidelines focused on the diagnosis, treatment and management of patients with chronic coronary disease (CCD).
Tracking data from more than 10,000 patients, researchers shared their findings in Diabetes, Obesity and Metabolism.
READ MORE >

Why patients living with HIV face a heightened risk of cardiovascular disease

The NIH-funded study was published in Arteriosclerosis, Thrombosis and Vascular Biology.

READ MORE >
Kidney Heart Brain Body
Share on Twitter Share on Facebook Share on Linkedin

Why patients living with HIV face a heightened risk of cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Kidney Heart Brain Body
The NIH-funded study was published in Arteriosclerosis, Thrombosis and Vascular Biology.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme